Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2347
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSambrook, P-
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorKeraudren, V-
dc.contributor.authorGaines, K-
dc.contributor.authorLeung, A-
dc.contributor.authorMelton, M-
dc.date.accessioned2007-11-13T16:21:22Z-
dc.date.available2007-11-13T16:21:22Z-
dc.date.issued2003-
dc.identifier.citationBONE, 32(5). p. S220-S221-
dc.identifier.issn8756-3282-
dc.identifier.urihttp://hdl.handle.net/1942/2347-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.titleEfficacy of Fosamax vs. evista comparison trial (effect-international): Results at 6 months-
dc.typeJournal Contribution-
dc.identifier.epageS221-
dc.identifier.issue5-
dc.identifier.spageS220-
dc.identifier.volume32-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notesRoyal N Shore Hosp, Sydney, NSW, Australia. LUC, Biomed Res Inst, Diepenbeek, Belgium. Merck & Co Inc, Whitehouse Stn, NJ USA.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000183123300641-
item.fulltextNo Fulltext-
item.fullcitationSambrook, P; GEUSENS, Piet; Keraudren, V; Gaines, K; Leung, A & Melton, M (2003) Efficacy of Fosamax vs. evista comparison trial (effect-international): Results at 6 months. In: BONE, 32(5). p. S220-S221.-
item.contributorSambrook, P-
item.contributorGEUSENS, Piet-
item.contributorKeraudren, V-
item.contributorGaines, K-
item.contributorLeung, A-
item.contributorMelton, M-
item.accessRightsClosed Access-
crisitem.journal.issn8756-3282-
crisitem.journal.eissn1873-2763-
Appears in Collections:Research publications
Show simple item record

Page view(s)

18
checked on Jul 28, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.